T3 Defense Restores $250M Shelf Capacity in Amendment No. 2
DFNS sits 32% above its 52-week low of $3.7 on light trading volume (0.1× avg).
Summary
T3 Defense filed Amendment No. 2 to its shelf registration, restoring $250 million of registered capacity after cutting it to $125 million on October 2. No shares have been sold; the company now has broad authorization to raise capital while it works through a Nasdaq equity deficiency and going-concern concerns.
Key Events · Financing and Capital Events · DFNS
-
Shelf Capacity Restored to $250M
Amendment No. 2 registers up to $250,000,000 of common stock, preferred stock, debt securities, warrants, subscription rights and units, reversing the reduction to $125 million disclosed on October 2, 2026.
-
No Securities Sold Yet
This is authorization only. Actual sales require a prospectus supplement setting price and terms; proceeds are earmarked for general corporate purposes, working capital and manufacturing.
-
Dilution Risk on Tiny Share Base
Only 3,366,384 common shares were outstanding as of October 20, 2026, so any material draw on the shelf would be substantially dilutive to current holders.
-
Nasdaq Equity Deficiency Overhang
The company received a Nasdaq minimum-stockholders'-equity notice on August 20, 2026 and reiterated going-concern risk in its August 18, 2026 10-Q; the shelf is its main tool to cure the deficiency.
Analysis · DFNS · Trade & Services
T3 Defense has doubled its registered shelf back to $250 million, reversing the October 2, 2026 amendment that had cut it to $125 million. No securities have been sold — this is permission to issue up to $250 million of stock, preferred, debt, warrants, rights or units from time to time, and nothing hits the market until a prospectus supplement prices an actual deal. The context is what makes it matter: the company is under a Nasdaq minimum-stockholders'-equity notice from August 20, 2026, carried going-concern language in its August 18 10-Q, and borrowed $3 million from Esousa at 12% in September. Restoring full shelf capacity gives it the widest possible runway to raise equity into a stock that trades at $4.87 with only 3,366,384 shares outstanding — meaning any meaningful raise would be heavily dilutive to existing holders. The filing also lays out the Series B Preferred terms, including a $21.375 conversion price and price-based anti-dilution protection, so future issuance below that level would add further share pressure.
How filings like this one have moved
In the 30 days to Oct 21, 2026, 28.9% of the 1511 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.54%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DFNS was trading at $4.87 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $16M. The 52-week trading range was $3.70 to $1,147.50. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.